EL
Elutia Inc
ELUT · NASDAQ
$0.81 -4.91% (-$0.04)
1M -15.16%
Market Cap $35.8M
P/E Ratio 0.69x
Div. Yield -
ROE 940.81%
Bulios Fair Price
$0.6
25.9% downside
Current Price
$0.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ELUT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
85 /100
Cheap P/S 2.95x
P/B 2.27x
P/E 0.69x
Growth
0 /100
Declining Rev. growth 19.82%
FCF growth N/A
Book val. growth N/A
Profitability
40 /100
Moderate FCF margin 374.76%
Op. margin 194.03%
Gross margin 57.82%
Quality
48 /100
Average Asset turnover 0.28x
ROA 118.69%
ROIC 77.75%
Debt
88 /100
Low Current ratio 1.77x
Int. coverage 7.43x
Debt/Equity 0.28x
Stability
59 /100
Moderate Profitable years 1
EPS volatility 26.56%
Beta 0.88x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ELUT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
C. Randal Mills
Employees
26
Headquarters
Gaithersburg
Upcoming events
12 NOV
Earnings
Upcoming earnings report